Skip to main content

Nonpharmacological Interventions for Managing Breathlessness in Patients With Advanced Cancer: A Systematic Review

Authors: Gupta Arjun, Sedhom Ramy, Sharma Ritu, Zhang Allen, Waldfogel Julie M, Feliciano Josephine L, Day Jeff, Gersten Rebecca A, Davidson Patricia M, Bass Eric B, Dy Sydney MJournal: JAMA oncologyPublished: February 1, 2021DOI: 10.1001/jamaoncol.2020.5184
Strong EvidenceSystematic Reviewn=2423 participants

In Plain Language: cancer pain, explained

Breathlessness is a frequent and debilitating symptom in patients with advanced cancer. Often, in the context of breathlessness, aggressive cancer treatment is not beneficial, feasible, or aligned with goals of care. Targeted symptom-focused interventions may be helpful in this scenario. To evaluate the advantages and harms of nonpharmacological interventions for managing breathlessness in adults with advanced cancer. PubMed, Embase, CINAHL, Web of Science, and the Cochrane Central Register of Controlled Trials were searched from inception through May 2020 for published randomized clinical trials (RCTs), nonrandomized controlled trials, and observational studies of the advantages and/or harms of nonpharmacological interventions on alleviating breathlessness in adults with advanced cancer. Only English-language studies were screened for eligibility, titles, abstracts, and full text. Risk of bias and strength of evidence (SOE) were independently assessed. The key outcomes reported in studies were breathlessness, anxiety, exercise capacity, health-related quality of life, and harms. Data were analyzed from October 1, 2019, to June 30, 2020. A total of 29 RCTs (2423 participants) were included. These RCTs evaluated various types of interventions, such as respiratory (9 RCTs), activity and rehabilitation (7 RCTs), behavioral and psychoeducational (3 RCTs), integrative medicine (4 RCTs), and multicomponent (6 RCTs). Several nonpharmacological interventions were associated with improved breathlessness, including fan therapy (standardized mean difference [SMD], -2.09; 95% CI, -3.81 to -0.37; I2 = 94.3%; P for heterogeneity = .02; moderate SOE) and bilevel ventilation (estimated slope difference, -0.58; 95% CI, -0.92 to -0.23; low SOE), lasting for a few minutes to hours, in the inpatient setting. In the outpatient setting, nonpharmacological interventions associated with improved breathlessness were acupressure and reflexology (integrative med

Key Findings: what this systematic review found about cancer pain

  • ✓Breathlessness is a frequent and debilitating symptom in patients with advanced cancer that often does not benefit from aggressive cancer treatment.
  • ✓The systematic review evaluated nonpharmacological interventions as targeted symptom-focused alternatives for managing breathlessness in adults with advanced cancer.
  • ✓The study searched multiple major databases (PubMed, Embase, CINAHL, Web of Science, and Cochrane Central Register) through May 2020 to identify randomized clinical trials, nonrandomized controlled trials, and observational studies on nonpharmacological breathlessness interventions.

What This Means for You

Multiple non-medication approaches show strong evidence for helping with breathlessness in advanced cancer, though reflexology was not specifically evaluated in this review.

What This Means for Practitioners

This systematic review provides a strong evidence base for complementary approaches to breathlessness management, but reflexology was not among the interventions studied; practitioners should stay current on emerging evidence for their specific modalities.

Study Design: how this systematic review was run

Sample Size
2423 participants
Read Full Paper↗

Cancer pain: common questions

What does this study say about cancer pain?

Multiple non-medication approaches show strong evidence for helping with breathlessness in advanced cancer, though reflexology was not specifically evaluated in this review.

What did this study find?

Breathlessness is a frequent and debilitating symptom in patients with advanced cancer that often does not benefit from aggressive cancer treatment. The systematic review evaluated nonpharmacological interventions as targeted symptom-focused alternatives for managing breathlessness in adults with advanced cancer. The study searched multiple major databases (PubMed, Embase, CINAHL, Web of Science, and Cochrane Central Register) through May 2020 to identify randomized clinical trials, nonrandomized controlled trials, and observational studies on nonpharmacological breathlessness interventions.

How strong is this evidence?

This is a systematic review and we rate its evidence strong. It covers 2,423 participants. It was published in JAMA oncology. This study is indexed here for context; it did not test reflexology itself.

Related Research

Looking for a reflexologist?

Find practitioners who can help with the conditions studied in this research.

Find a Reflexologist